Cargando…

GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma

The outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for adult T-cell leukemia/lymphoma (ATL) is still unsatisfactory. To illustrate the advantages and disadvantages of each donor source, we performed a nationwide retrospective study of graft-versus-host disease (GVHD)-free,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muranushi, Hiroyuki, Shindo, Takero, Hishizawa, Masakatsu, Tokunaga, Masahito, Wake, Atsushi, Nakano, Nobuaki, Eto, Tetsuya, Hidaka, Michihiro, Choi, Ilseung, Miyamoto, Toshihiro, Uchida, Naoyuki, Moriuchi, Yukiyoshi, Miyazaki, Yasuhiko, Fukuda, Takahiro, Ichinohe, Tatsuo, Atsuta, Yoshiko, Kato, Koji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359445/ https://www.ncbi.nlm.nih.gov/pubmed/32665675 http://dx.doi.org/10.1038/s41409-020-00996-y

Ejemplares similares

Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning
por: Iwasaki, Makoto, et al.
Publicado: (2022)

Dual inhibition of the MEK/ERK and PI3K/AKT pathways prevents pulmonary GVHD suppressing perivenulitis and bronchiolitis
por: Muranushi, Hiroyuki, et al.
Publicado: (2022)

Pathophysiology of GvHD and Other HSCT-Related Major Complications
por: Ghimire, Sakhila, et al.
Publicado: (2017)

Oral Cancer in HSCT Pediatric Patients Arising on GVHD: A Comprehensive Review
por: Cantile, Tiziana, et al.
Publicado: (2022)

Targeting SLP76:ITK interaction separates GVHD from GVL in allo-HSCT
por: Mammadli, Mahinbanu, et al.
Publicado: (2021)

Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT
por: Mammadli, Mahinbanu, et al.
Publicado: (2020)

A nomogram model for predicting ocular GVHD following allo-HSCT based on risk factors
por: Wang, Wen-hui, et al.
Publicado: (2023)

Genetic manipulation resulting in decreased donor chondroitin sulfate synthesis mitigates hepatic GVHD via suppression of T cell activity
por: Tamura, Suguru, et al.
Publicado: (2023)

Next‐generation sequencing in two cases of de novo acute basophilic leukaemia
por: Shimizu, Takuya, et al.
Publicado: (2021)

Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation
por: Lorentino, Francesca, et al.
Publicado: (2022)

Evaluation of Cyclosporine Pharmacokinetic, Monitoring, and Dosing Parameters for GVHD Prophylaxis in Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Tafazoli, Ali, et al.
Publicado: (2019)

PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients
por: Hossain, Mohammad S., et al.
Publicado: (2017)

Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCT
por: Luo, Rongmu, et al.
Publicado: (2022)

PD-1 Checkpoint Blockade in Patients for Acute Myeloid Leukemia after HSCT Relapse Resulted in Severe GVHD and sHLH
por: Du, Zhi zhuo, et al.
Publicado: (2022)

Blood Stream Infection (BSI) and Acute Graft Versus Host Disease (GVHD) after Hematopoietic Stem Cell Transplantation (HSCT) are Associated
por: Poutsiaka, Debra D, et al.
Publicado: (2010)

BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT
por: Copsel, Sabrina N., et al.
Publicado: (2019)

Early CD8(+)-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT
por: Ranti, Juha, et al.
Publicado: (2018)

New Clue: Prediction from Cell-Free DNA
por: Sanders, Yan Y.
Publicado: (2020)

S237: ORCA-T, AN ENGINEERED ALLOGRAFT, RESULTS IN HIGH GVHD-FREE AND RELAPSE-FREE SURVIVAL FOLLOWING MYELOABLATIVE CONDITIONING FOR HEMATOLOGICAL MALIGNANCIES
por: Meyer, E., et al.
Publicado: (2022)

Steroid-resistant intestinal aGVHD and refractory CMV and EBV infections complicated by haplo-HSCT were successfully rescued by FMT and CTL infusion
por: Qi, Ling, et al.
Publicado: (2021)

Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients
por: Storci, Gianluca, et al.
Publicado: (2023)

Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases
por: Zaidman, Irina, et al.
Publicado: (2023)

Therapeutic Effects of HLA-G5 Overexpressing hAMSCs on aGVHD After Allo-HSCT: Involving in the Gut Microbiota at the Intestinal Barrier
por: Bu, Xiaoyin, et al.
Publicado: (2023)

Human Amniotic Mesenchymal Stem Cells Alleviate aGVHD after allo-HSCT by Regulating Interactions between Gut Microbiota and Intestinal Immunity
por: Bu, Xiaoyin, et al.
Publicado: (2023)

P1306: IMPACT OF HLA DISPARITY ON THE RISK OF OVERALL MORTALITY IN PATIENTS WITH EXTENSIVE CHRONIC GVHD
por: Fuji, Shigeo, et al.
Publicado: (2023)

Inflammasomes in antiviral immunity: clues for influenza vaccine development
por: Yamazaki, Tatsuya, et al.
Publicado: (2014)

Efficacy of palifermin on oral mucositis and acute GVHD after hematopoietic stem cell transplantation (HSCT) in hematology malignancy patients: a meta-analysis of trials
por: Mozaffari, Hamid Reza, et al.
Publicado: (2017)

Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation
por: Iwasaki, Makoto, et al.
Publicado: (2022)

Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia
por: Fan, Qian, et al.
Publicado: (2017)

SARS-CoV-2 Infection and Active, Multiorgan, Severe cGVHD After HSCT for Adolescent ALL: More Luck Than Understanding? A Case Report
por: Zubarovskaya, Natalia, et al.
Publicado: (2022)

Posttransplant de novo DSA and NDSA affect GvHD, OS, and DFS after haplo-HSCT in patients without pre-existing HLA antibodies of hematological malignancies
por: Wang, Lan, et al.
Publicado: (2022)

Dentistry consensus on HSCT – Part III: Special topics – Dentistry on HSCT
por: Santos, Paulo Sérgio da Silva, et al.
Publicado: (2023)

Dental consensus on HSCT – Part II: dental Care during HSCT
por: Gobbi, Marcella Ferreira, et al.
Publicado: (2023)

Thyroid dysfunction after hematopoietic stem cell transplantation in children: older age and acute GVHD might be risk factors of thyroid dysfunction during 3 months after HSCT
por: Cho, Won Kyoung, et al.
Publicado: (2013)

Long-term follow-up of patients with ATL after autologous stem cell transplantation
por: Utsunomiya, Atae, et al.
Publicado: (2022)

A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
por: Schäfer, Henning, et al.
Publicado: (2021)

Early myeloid-derived suppressor cells (HLA-DR(−)/(low)CD33(+)CD16(−)) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT
por: Wang, Ke, et al.
Publicado: (2019)

GVHD Prophylaxis 2020
por: Gooptu, Mahasweta, et al.
Publicado: (2021)

Blockade of Vascular Endothelial Growth Factor (VEGF) Aggravates the Severity of Acute Graft-versus-host Disease (GVHD) after Experimental Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
por: Kim, Ai-Ran, et al.
Publicado: (2011)

Can Milking-Like Effect Be the First Clue of a Ventricular Free Wall Rupture?
por: Ramirez Damera, Ramses, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m63abmislldf9ugsfmimffa5al